Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "BIS"

231 News Found

Blue Star opens medical diagnostic equipment refurbishment facility in Maharashtra
Medical Device | April 03, 2022

Blue Star opens medical diagnostic equipment refurbishment facility in Maharashtra

Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India


Solvay partners with Mitsubishi Chemical to recycle end-of-life medical components
News | March 29, 2022

Solvay partners with Mitsubishi Chemical to recycle end-of-life medical components

New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.


Abbisko Therapeutics enters global tie-up with Lilly to develop novel molecules
Biotech | January 18, 2022

Abbisko Therapeutics enters global tie-up with Lilly to develop novel molecules

The tie-up combines Abbisko Therapeutics’ proprietary drug discovery platform with Lilly’s disease and discovery expertise


Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme
Biotech | December 15, 2021

Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme

Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales


Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
News | June 23, 2026

Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results

The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines


We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
interviews | June 16, 2026

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene

Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships


Dr. Rishi Raj Borah honoured with Champions of Change Award
Healthcare | June 12, 2026

Dr. Rishi Raj Borah honoured with Champions of Change Award

Orbis India Country Director recognized by the Lions Council of India for efforts to expand access to quality eye care among underserved communities.


AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations
Clinical Trials | June 09, 2026

AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations

The company will present 21 oral and poster presentations spanning investigational and approved therapies


Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types
Clinical Trials | June 03, 2026

Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types

The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials


BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial
Clinical Trials | June 02, 2026

BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial

The safety profile was described as manageable, though not without notable toxicities